Occurrence of benzodiazepines and nonbenzodiazepines usage among newly-onset of peritoneal dialysis versus hemodialysis patients
Wen-Teng Lee, Mingchih Chen, Yu-Wei Fang, Wei-Shan Chang, Kai-Yuan Hsiao, Ben-Chang Shia, Hung-Hsiang Liou, Ming-Hsien Tsai · 2025
Read Occurrence of benzodiazepines and nonbenzodiazepines usage among newly-onset of peritoneal dialysis versus hemodialysis patients by Wen-Teng Lee, Mingchih Chen, Yu-Wei Fang, Wei-Shan Chang, Kai-Yuan Hsiao, Ben-Chang Shia, Hung-Hsiang Liou, Ming-Hsien Tsai (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12763926.txt.
Description
A peer-reviewed research article from Europe PMC (2025). BackgroundThe use of central nervous system depressants, including benzodiazepines (BZDs) and nonbenzodiazepine hypnotics (Z-drugs), is increasingly observed in chronic dialysis patients. Hemodialysis (HD) and peritoneal dialysis (PD) patients differ in physiological stress and neuropsychiatric profiles, yet both groups are exposed to medications such as BZDs and Z-drugs, whose adverse effects including sedation, cognitive impairment, and increased mortality, may further compound the psychological vulnerability and survival risks inherent to these dialysis populations.
Catalog record
| CREATOR | Wen-Teng Lee, Mingchih Chen, Yu-Wei Fang, Wei-Shan Chang, Kai-Yuan Hsiao, Ben-Chang Shia, Hung-Hsiang Liou, Ming-Hsien Tsai |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |